Elevation Oncology: Funding, Investors & Team (Sep 2026)
Height Oncology makes genomic tests noteworthy by specifically creating medications to hinder the particular adjustments that have been distinguished as drivers of sickness. Its lead up-and-comer, seribantumab, which restrains cancer development driven by NRG1 combinations, is as of now being clinically tried in the Phase 2 CRESTONE study for patients with growths of any beginning that have a NRG1 combination.
Elevation Oncology has raised $100M across 2 funding rounds on record, the most recent an undisclosed round of $50.0M announced in Jun 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Elevation Oncology Company Profile and Key Stats
Latest funding round on record: Jun 2023.
Elevation Oncology Funding Rounds
Elevation Oncology raised $50.0M in a Post-IPO Debt announced in Jul 2022.
11 months later, an undisclosed round of $50.0M was announced in Jun 2023.
Elevation Oncology Founders and Leadership Team
No contact details are on record for this team yet.
Elevation Oncology Funding Compared to Other Biotechnology Startups
Elevation Oncology's latest round of $50.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Elevation Oncology in Biotechnology and New York
Companies Similar to Elevation Oncology
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Elevation Oncology Funding FAQs
What does Elevation Oncology do?
Height Oncology makes genomic tests noteworthy by specifically creating medications to hinder the particular adjustments that have been distinguished as drivers of sickness. Its lead up-and-comer, seribantumab, which restrains cancer development driven by NRG1 combinations, is as of now being clinically tried in the Phase 2 CRESTONE study for patients with growths of any beginning that have a NRG1 combination.
How much funding has Elevation Oncology raised?
Elevation Oncology has raised $100M across 2 rounds on record. The most recent is an undisclosed round of $50.0M announced in Jun 2023.
When did Elevation Oncology last raise funding?
Elevation Oncology's most recent funding round on record is an undisclosed round of $50.0M, announced in Jun 2023.
Who founded Elevation Oncology?
FundedIQ lists Shawn Leland (Founder) at Elevation Oncology.
Where is Elevation Oncology headquartered?
Elevation Oncology is based in New York, United States.
How many employees does Elevation Oncology have?
Elevation Oncology is in the 11-50 employee band.
How does Elevation Oncology's funding compare to other Biotechnology startups?
Elevation Oncology's latest round of $50.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Elevation Oncology Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Elevation Oncology is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.